These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37521304)

  • 1. Case report: Expanding the phenotype of
    Cesaroni CA; Pollazzon M; Mancini C; Rizzi S; Cappelletti C; Pizzi S; Frattini D; Spagnoli C; Caraffi SG; Zuntini R; Trimarchi G; Niceta M; Radio FC; Tartaglia M; Garavelli L; Fusco C
    Front Neurol; 2023; 14():1207176. PubMed ID: 37521304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: FOXP1 syndrome caused by a
    Chen M; Sun Y; Qian Y; Chen N; Li H; Wang L; Dong M
    Front Genet; 2022; 13():926070. PubMed ID: 35991577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
    Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
    Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Meerschaut I; Rochefort D; Revençu N; Pètre J; Corsello C; Rouleau GA; Hamdan FF; Michaud JL; Morton J; Radley J; Ragge N; García-Miñaúr S; Lapunzina P; Bralo MP; Mori MÁ; Moortgat S; Benoit V; Mary S; Bockaert N; Oostra A; Vanakker O; Velinov M; de Ravel TJ; Mekahli D; Sebat J; Vaux KK; DiDonato N; Hanson-Kahn AK; Hudgins L; Dallapiccola B; Novelli A; Tarani L; Andrieux J; Parker MJ; Neas K; Ceulemans B; Schoonjans AS; Prchalova D; Havlovicova M; Hancarova M; Budisteanu M; Dheedene A; Menten B; Dion PA; Lederer D; Callewaert B
    J Med Genet; 2017 Sep; 54(9):613-623. PubMed ID: 28735298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) With Language Impairment Accompanied by Developmental Disability Caused by Forkhead Box Protein 1 (FOXP1) Exon Deletion: A Case Report.
    Alenezi S; Alyahya A; Aldhalaan H
    Cureus; 2021 Dec; 13(12):e20595. PubMed ID: 35103171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole genome sequencing identifies a de novo 2.1 Mb balanced paracentric inversion disrupting FOXP1 and leading to severe intellectual disability.
    Vuillaume ML; Cogné B; Jeanne M; Boland A; Ung DC; Quinquis D; Besnard T; Deleuze JF; Redon R; Bézieau S; Laumonnier F; Toutain A
    Clin Chim Acta; 2018 Oct; 485():218-223. PubMed ID: 29969624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A de novo FOXP1 variant in a patient with autism, intellectual disability and severe speech and language impairment.
    Lozano R; Vino A; Lozano C; Fisher SE; Deriziotis P
    Eur J Hum Genet; 2015 Dec; 23(12):1702-7. PubMed ID: 25853299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective investigation of FOXP1 syndrome.
    Siper PM; De Rubeis S; Trelles MDP; Durkin A; Di Marino D; Muratet F; Frank Y; Lozano R; Eichler EE; Kelly M; Beighley J; Gerdts J; Wallace AS; Mefford HC; Bernier RA; Kolevzon A; Buxbaum JD
    Mol Autism; 2017; 8():57. PubMed ID: 29090079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy.
    Kanani F; Titheradge H; Cooper N; Elmslie F; Lees MM; Juusola J; Pisani L; McKenna C; Mignot C; Valence S; Keren B; Lachlan K; ; Balasubramanian M
    Am J Med Genet A; 2020 Apr; 182(4):713-720. PubMed ID: 31926053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features and genetic analysis of three children with mental retardation, language impairment and autistic features due to de novo variants of FOXP1 gene].
    Hua R; Xu X; Wu D; Yang L; Yuan J; Zhu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Dec; 38(12):1194-1198. PubMed ID: 34839505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A de novo PAK1 likely pathogenic variant and a de novo terminal 1q microdeletion in a Chinese girl with global developmental delay, severe intellectual disability, and seizures.
    Zhuang J; Xie M; Yao J; Fu W; Zeng S; Jiang Y; Wang Y; Xie Y; Wang G; Chen C
    BMC Med Genomics; 2023 Jan; 16(1):3. PubMed ID: 36624491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXP1 mutations cause intellectual disability and a recognizable phenotype.
    Le Fevre AK; Taylor S; Malek NH; Horn D; Carr CW; Abdul-Rahman OA; O'Donnell S; Burgess T; Shaw M; Gecz J; Bain N; Fagan K; Hunter MF
    Am J Med Genet A; 2013 Dec; 161A(12):3166-75. PubMed ID: 24214399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A De Novo FOXP1 Truncating Mutation in a Patient Originally Diagnosed as C Syndrome.
    Urreizti R; Damanti S; Esteve C; Franco-Valls H; Castilla-Vallmanya L; Tonda R; Cormand B; Vilageliu L; Opitz JM; Neri G; Grinberg D; Balcells S
    Sci Rep; 2018 Jan; 8(1):694. PubMed ID: 29330474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of a de novo c.2605C > T (p.Pro869Ser) change in the MED13L gene and review of the literature for MED13L-related intellectual disability.
    Yi Z; Zhang Y; Song Z; Pan H; Yang C; Li F; Xue J; Qu Z
    Ital J Pediatr; 2020 Jul; 46(1):95. PubMed ID: 32646507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trio exome sequencing identified a novel de novo WASF1 missense variant leading to recurrent site substitution in a Chinese patient with developmental delay, microcephaly, and early-onset seizures: A mutational hotspot p.Trp161 and literature review.
    Zhao A; Zhou R; Gu Q; Liu M; Zhang B; Huang J; Yang B; Yao R; Wang J; Lv H; Wang J; Shen Y; Wang H; Chen X
    Clin Chim Acta; 2021 Dec; 523():10-18. PubMed ID: 34478686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment.
    Hamdan FF; Daoud H; Rochefort D; Piton A; Gauthier J; Langlois M; Foomani G; Dobrzeniecka S; Krebs MO; Joober R; Lafrenière RG; Lacaille JC; Mottron L; Drapeau P; Beauchamp MH; Phillips MS; Fombonne E; Rouleau GA; Michaud JL
    Am J Hum Genet; 2010 Nov; 87(5):671-8. PubMed ID: 20950788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo FBXO11 mutations are associated with intellectual disability and behavioural anomalies.
    Fritzen D; Kuechler A; Grimmel M; Becker J; Peters S; Sturm M; Hundertmark H; Schmidt A; Kreiß M; Strom TM; Wieczorek D; Haack TB; Beck-Wödl S; Cremer K; Engels H
    Hum Genet; 2018 May; 137(5):401-411. PubMed ID: 29796876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MED13 mutation: A novel cause of developmental and epileptic encephalopathy with infantile spasms.
    Trivisano M; De Dominicis A; Micalizzi A; Ferretti A; Dentici ML; Terracciano A; Calabrese C; Vigevano F; Novelli G; Novelli A; Specchio N
    Seizure; 2022 Oct; 101():211-217. PubMed ID: 36087421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
    Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
    Mol Autism; 2019; 10():35. PubMed ID: 31649809
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.